Diabetes and Medicare Supplies – Part 2

If information is power than knowing as much as you can about the Medicare benefits you’re entitled to can be very helpful in your care. The Center for Medicare and Medicaid Services provides more details.

Diabetes and Medicare Supplies – Part 2If information is power than knowing as much as you can about the Medicare benefits you’re entitled to can be very helpful in your care. The Center for Medicare and Medicaid Services provides more details.

Before a beneficiary gets a supply, it is important for them to ask the supplier or pharmacy the following questions:

  • Are you enrolled in Medicare?
  • Do you accept assignment?

If the answer to either of these two (2) questions is “no,” they should call another supplier or pharmacy in their area who answers “yes” to be sure their purchase is covered by Medicare, and to save them money.

If a beneficiary cannot find a supplier or pharmacy in their area that is enrolled in Medicare and accepts assignment, they may want to order their supplies through the mail, which may also save them money.

Therapeutic Shoes and Inserts
If a beneficiary has Medicare Part B, has diabetes, and meets certain conditions (see below), Medicare will cover therapeutic shoes if they need them. The types of shoes that are covered each year include one of the following:

  • One pair of depth-inlay shoes and three pairs of inserts; or
  • One pair of custom-molded shoes (including inserts) if the beneficiary cannot wear depth-inlay shoes because of a foot deformity and two additional pairs of inserts.

Note: In certain cases, Medicare may also cover shoe modifications instead of inserts.
In order for Medicare to pay for the beneficiary’s therapeutic shoes, the doctor treating their diabetes must certify that they meet all of the following three conditions:

  • They have diabetes;
  • They have at least 1 of the following conditions in one or both feet:
  • Partial or complete foot amputation;
  • Past foot ulcers;
  • Calluses that could lead to foot ulcers;
  • Nerve damage because of diabetes with signs of problems with calluses;
  • Poor circulation; or
  • Deformed foot;
  • They are being treated under a comprehensive diabetes care plan and need therapeutic shoes and/or inserts because of diabetes.

Medicare also requires the following:

  • A podiatrist or other qualified doctor must prescribe the shoes, and
  • A doctor or other qualified individual like a pedorthist, orthotist, or prosthetist must fit and provide the shoes to the beneficiary.

Medicare helps pay for one pair of therapeutic shoes and inserts per calendar year, and the fitting of the shoes or inserts is covered in the Medicare payment for the shoes.

Insulin Pumps and the Insulin Used in the Pumps
Insulin pumps worn outside the body (external), including the insulin used with the pump, may be covered for some people with Medicare Part B who have diabetes and who meet certain conditions. If a beneficiary needs to use an insulin pump, their doctor will need to prescribe it. In the Original Medicare Plan, the beneficiary pays 20% of the Medicare-approved amount after the yearly Part B deductible. Medicare will pay 80% of the cost of the insulin pump. Medicare will also pay for the insulin that is used with the insulin pump.

Medicare Part B covers the cost of insulin pumps and the insulin used in the pumps. However, if the beneficiary injects their insulin with a needle (syringe), Medicare Part B does not cover the cost of the insulin, but the Medicare prescription drug benefit (Part D) covers the insulin and the supplies necessary to inject it. This includes syringes, needles, alcohol swabs and gauze. The Medicare Part D plan will cover the insulin and any other medications to treat diabetes at home as long as the beneficiary is on the Medicare Part D plan’s formulary. (Source: cms.gov)

Diabetes Connection to the Bone Cells

It’s not often that you hear of medical science discussing diabetes and bones in the same sentence. Usually the heart and kidneys are the discussed in connection with diabetes, but new research suggests that the human bones may have a bearing on how the human body manages insulin.

bone cells and diabetesIt’s not often that you hear of medical science discussing diabetes and bones in the same sentence. Usually the heart and kidneys are the discussed in connection with diabetes, but new research suggests that the human bones may have a bearing on how the human body manages insulin.

MedPageToday indicates, “In the July 23 issue of Cell, [and] from two separate research teams [there is an indication] that insulin receptors in osteoblasts mediate release of the hormone osteocalcin, which speeds up glucose metabolism elsewhere in the body.”

MedicineNet.com defines osteoblasts as, “A cell that makes bone.” Meanwhile, “The hormone osteocalcin is secreted solely by osteoblasts (bone making cells) and thought to play a role in the body’s metabolic regulation and is pro-osteoblastic, or bone-building,” according to Wikipedia.

According to Gerard Karsenty, MD, PhD, of Columbia University in New York City, “The two studies suggest that drugs working through the osteocalcin pathway, if not the hormone itself, could be effective treatments for type 2 diabetes.

“Insulin signaling in osteoblasts [is] a critical link between bone remodeling and energy metabolism,” cited MedPageToday.com

The exciting part of this research is the fact that this provides a new link of potential in how the body works to correct health issues. As mentioned in the opening paragraph it is not often that anyone has spoken about diabetes and bone health in the same sentence.

The end result could be that individuals with diabetes may want to gain as much information about how the human bones can actually help regular blood sugar (glucose) as possible.

MedPageToday indicated these, “experiments also revealed what they called a “previously unappreciated” function of insulin in bone — that it boosts activity of an osteoblast regulatory molecule called Runx2, the end effect being that insulin helps promote osteoblast differentiation.”

The research on this finding was “funded by the Fond de la Recherche en Sante du Quebec, the National Institutes of Health, and the Juvenile Diabetes Research Foundation.”

The long and short of the research suggests that it is possible the bone making cells interact in a more significant way with diabetes by infusing the hormone osteocalcin into the body. This hormone is helpful in regulating diabetes. The hormone appears to act in concert with the bone-making cells to create an atmosphere that is equipped to help with the in-body care needed to thrive with diabetes.

According to MedPageToday both research groups suggested, “In total, the findings demonstrate the delicate and interactive nature of the processes underlying bone formation and resorption.”

The research may further indicate what possible ways this knowledge can be used to accelerate the body’s ability to accept a more efficient flow of information and successful implementation and absorption of insulin within the body, and used by bone making cells.

The body is a very complex organism that is often discovered to be more complex than we ever realized. DNA is an example of the complexity, but even within that undeniably unique set of body blue prints we continue to learn more and more about not only the various parts of our internal structure, but also how those parts interact in ways we never imagined.

These latest studies remain a prime example of how that plays out in scientific data and potential medical fixes for those occasions when two parts of the body that normally work well together are in the midst of a struggle.

Diabetes and the Potential Impact of AMPK

If you’ve ever watched a survival type show on television then you know there are extremes in food availability that people endure and they seem to come out of these issues safely. There is a chromosome protein that acts as a rescue device and the discovery of how it functions may have a huge impact on how diabetes is treated.

According to Medical News Today, “Researchers at McGill University and University of Pennsylvania have uncovered new insights into how a protein known as the AMP-activated protein kinase, or AMPK, a master regulator of metabolism, controls how our cells generate energy.”

Imagine if you will, a drill sergeant in the Army. He commissions soldiers to go from one place to the next to fulfill the needs of the overall operation. He’s in charge of many soldiers and each is told what to do and when to do it. This is a picture of what AMPK is like in the human body.

If the AMPK determines the body’s resources are not required for energy then it will not willingly allocated energy resources without just cause.

McGill Professor Russell Jones is quoted in Medical News Today as saying, “”The discovery that AMPK goes directly to the DNA to affect gene transcription is a breakthrough in our understanding how signals from outside the cell are transmitted to change gene expression. It is like an electrical circuit. We have figured out how AMPK mediates the connection.”

If you’re wondering why this is big news the answer lies in what medical science can potentially do with this information. They may be able to effectively send new orders to the AMPK allowing the use of energy cells to be used in metabolism – even during times when the AMPK would not normally do so.

As a society we’ve encountered an alteration in our overall lifestyle. Where once we were more active in physical labor today we are much more sedentary so our bodies are not used to the idea of needing to burn added fat or energy cells.

Medical News Today helps explain the process. “AMPK’s main role is to sense cell stress. In this study, cells were stressed with ultraviolet radiation and low levels of glucose, a common source of cell energy. In the sequence of events after stress, AMPK picks up the cell-stress signal and travels to the nucleus to bind to the tumor suppressor gene p53. This in turn, causes a phosphate to be added to a histone near the p21 gene, which activates transcription. The function of the p21 protein is to stop or slow down the cell cycle.”

If medical science can simulate cell stress then it may be possible to induce a more effective use of glucose and a fat burning metabolism as it works to encourage AMPK to regulate a change that gains benefit from an effective use of blood glucose.

Medical News Today reports, “The work conducted by the researchers holds promise for new therapies for a number of diseases including diabetes and cancer. For example, AMPK is a target of metformin, the most commonly prescribed drug for the treatment of Type II diabetes. By understanding how AMPK can directly change gene expression, this may lead to the identification of new disease-associated targets and potential therapies.”

In the end this is one more potential therapy that may result in improved care for those who live with diabetes.

Diabetes and Medicare Supplies – Part 1

Diabetes and Medicare Supplies – Part 1It can sometimes be confusing to know what exactly is covered under the U.S. Government’s Medicare program when it comes to diabetes. The Center for Medicare and Medicaid Services provides some details.

MEDICARE – PART B

Medicare covers certain supplies if a beneficiary has Medicare Part B and has diabetes. These supplies include:

  • Blood glucose self-testing equipment and supplies;
  • Therapeutic shoes and inserts; and
  • Insulin pumps and the insulin used in the pumps

Blood Glucose Self-testing Equipment and Supplies

Blood glucose self-testing equipment and supplies are covered for all people with Medicare Part B who have diabetes. This includes those who use insulin and those who do not use insulin. These supplies include:

  • Blood glucose monitors;
  • Blood glucose test strips;
  • Lancet devices and lancets; and
  • Glucose control solutions for checking the accuracy of testing equipment and test strips.

Medicare Part B covers the same type of blood glucose testing supplies for people with diabetes whether or not they use insulin. However, the amount of supplies that are covered varies.

If the beneficiary

  • Uses insulin, they may be able to get up to 100 test strips and lancets every month, and 1 lancet device every 6 months.
  • Does not use insulin, they may be able to get 100 test strips and lancets every 3 months, and 1 lancet device every 6 months.

If a beneficiary’s doctor documents why it is medically necessary, Medicare will cover additional test strips and lancets for the beneficiary.

Medicare will only cover a beneficiary’s blood glucose self-testing equipment and supplies if they get a prescription from their doctor.

Their prescription should include the following information:

  • That they have diabetes;
  • What kind of blood glucose monitor they need and why they need it (i.e., if they need a special monitor because of vision problems, their doctor must explain that.);
  • Whether they use insulin; and
  • How often they should test their blood glucose.

A beneficiary needing blood glucose testing equipment and/or supplies:

  • Can order and pick up their supplies at their pharmacy;
  • Can order their supplies from a medical equipment supplier, but they will need a prescription from their doctor to place their order; and
  • Must ask for refills for their supplies.

Note: Medicare will not pay for any supplies not asked for, or for any supplies that were sent to a beneficiary automatically from suppliers. This includes blood glucose monitors, test strips, and lancets. Also, if a beneficiary goes to a pharmacy or supplier that is not enrolled in Medicare, Medicare will not pay. The beneficiary will have to pay the entire bill for any supplies from non-enrolled pharmacies or non-enrolled suppliers.

All Medicare-enrolled pharmacies and suppliers must submit claims for blood glucose monitor test strips. A beneficiary cannot submit a claim for blood glucose monitor test strips themselves. The beneficiary should make sure that the pharmacy or supplier accepts assignment for Medicare-covered supplies. If the pharmacy or supplier accepts assignment, Medicare will pay the pharmacy or supplier directly. Beneficiaries should only pay their coinsurance amount when they get their supply from their pharmacy or supplier for assigned claims. If a beneficiary’s pharmacy or supplier does not accept assignment, charges may be higher, and the beneficiary may pay more. They may also have to pay the entire charge at the time of service and wait for Medicare to send them its share of the cost. (Source: cms.gov)

Diabetes, Cashews & Dementia

cashews and diabetesWhat do cashews and dementia have in common? They are commonly linked with diabetes. The first as a preventative aid and the second a byproduct of uncontrolled diabetes.

According to TopNews, “A new study by the researchers from Universities of Montreal, Canada and de Yaounde Cameroun has indicated towards the effectiveness of the cashew seed extract against diabetes.”

Pierre Haddad is a professor of pharmacology in Montreal who indicated, “Cashew seeds extract have effectively stimulated the absorption of blood sugar by muscle cells, among all the extracts tested.”

The reason the research is significant is because the cashew is a natural and sustainable resource that can be used in cost effective treatment of diabetes. Obviously more research will be needed, but the use of cashews in the care of diabetes may be viewed as another positive in the ongoing quest to find treatments and an ultimate cure for diabetes.

Haddad is quoted by TopNews as saying, “Our study validates the traditional use of cashew tree products in diabetes and points to some of its natural components that can serve to create new oral therapies.”

Cashews come from a fruit known as cashew apples. The apple is small and typically rots within 24 hours of picking. The research extended to the apple, the leaf and the bark of the cashew apple trees. Cashews are said to be anti-inflammatory and can be used to control the blood sugar levels in those living with diabetes.

Meanwhile, TopNews also reported, “Mayo Clinic’s Florida campus and the University of California have conducted a research on whether dementia varies with people having diabetes or not. Blood samples of 211 people with dementia and 403 without dementia were collected to compare the ratio of two dissimilar types of amyloid beta proteins in blood.”

It has been said that Alzheimer’s is a form of diabetes because insulin levels are extremely low in patients with Alzheimer’s. However, the report suggests that dementia in diabetes is different than Alzheimers, “The findings show that people who have diabetes are more likely to get affected by vascular disease, which affects blood flow in brain vessels causing dementia. People who suffer from dementia without diabetes are affected by brain plaque deposits, which are generally found in Alzheimer patients,” said TopNews.

The study was published in the Archives of Neurology. TopNews reports, “Those having dementia without diabetes can cure the same by taking high levels of vitamin E in their meals, as Vitamin E guards the brain against oxidative stress, which causes Alzheimer.”

To avoid dementia in adults the findings suggest that, “The intake of four antioxidants — vitamin E, vitamin C, beta carotene and flavanoids — can improve the function of the memory.”

In diabetes, dementia is often the result of vessel damage between the heart and brain. By understanding the cause medical practitioners may be able to better guard against the instance of dementia by assisting their diabetic patients with information and medication that may prove helpful.

These two stories continue to point to the wide variety of tools researchers are using in order to gain a better understanding of diabetes and how it affects patients. Similarly they are also working to use every available resource to better the lives of their patients.

The overall care of those with diabetes continues to improve with each passing year and research findings like these assist in advancing the cause of care.

Medicare and Diabetes Prevention

There is a greater cost involved in treating diabetes than preventing it. The U.S. Government realizes this so they have included prevention programs in their Medicare plan.

While this list isn’t complete it does take a look at prevention programs related very specifically to diabetes and related illnesses for those who participate in Medicare.

Cardiovascular Screenings
Helps detect conditions that may lead to a heart attack or stroke. This service is covered every 5 years to test your cholesterol, lipid, and triglyceride levels. No cost for the test, but you generally have to pay 20% of the Medicare-approved amount for the doctor’s visit.

Diabetes Screenings
Checks for diabetes. These screenings are covered if you have any of the following risk factors: high blood pressure (hypertension), history of abnormal cholesterol and triglyceride levels (dyslipidemia), obesity, or a history of high blood sugar (glucose). Tests are also covered if you answer yes to two or more of the following questions:

  • Are you age 65 or older?
  • Are you overweight?
  • Do you have a family history of diabetes (parents, siblings)?
  • Do you have a history of gestational diabetes (diabetes during pregnancy), or did you deliver a baby weighing more than 9 pounds?

Based on the results of these tests, you may be eligible for up to two diabetes screenings every year. No cost for the test, but you generally have to pay 20% of the Medicare-approved amount for the doctor’s visit.
Diabetes Self-Management Training

For people with diabetes. Your doctor or other health care provider must provide a written order. You pay 20% of the Medicare-approved amount, and the Part B deductible applies.

EKG Screening
Medicare covers a one-time screening EKG if you get a referral for it as a result of your one-time “Welcome to Medicare” physical exam. You pay 20% of the Medicare-approved amount, and the Part B deductible applies. An EKG is also covered as a diagnostic test.
Flu Shots

Helps prevent influenza or flu virus. Covered once a flu season in the fall or winter. You need a flu shot for the current virus each year. No cost to you for the flu shot if the doctor accepts assignment for giving the shot.

Glaucoma Tests
Helps find the eye disease glaucoma. Covered once every 12 months for people at high risk for glaucoma. You are considered high risk for glaucoma if you have diabetes, a family history of glaucoma, are African-American and age 50 or older, or are Hispanic and age 65 or older. An eye doctor who is legally authorized by the state must do the tests. You pay 20% of the Medicare-approved amount, and the Part B deductible applies.

Medical Nutrition Therapy Services
Medicare may cover medical nutrition therapy and certain related services if you have diabetes or kidney disease, or you have had a kidney transplant in the last 36 months, and your doctor refers you for the service. You pay 20% of the Medicare-approved amount, and the Part B deductible applies.

Welcome to Medicare Physical Exam (one-time physical exam)
A one-time review of your health, and education and counseling about preventive services, including certain screenings, shots, and referrals for other care if needed. Medicare will cover this exam if you get it within the first 12 months you have Part B. You pay 20% of the Medicare-approved amount. When you make your appointment, let your doctor’s office know that you would like to schedule your “Welcome to Medicare” physical exam.

More information about these and other services can be found at the Medicare website

New Research May Mean Change in Diabetic Treatment

What would happen if medical science could put a tight reign on blood glucose levels? Would it have a significant impact on those living with diabetes? If so, how would it help? A five-year study provides some interesting insight.

According to Voice of America (VOA), “The government-funded study is called ACCORD, which stands for Action to Control Cardiovascular Risk in Diabetes. The study included high-risk diabetes patients – typically older and obese, with a history of complications.”

Conventional medical wisdom has been that tight control of blood glucose is helpful in all phases of diabetic self-management. However the findings pointed in a different direction, “Some patients got medicine to aggressively reduce cholesterol or blood pressure or their blood sugar levels. They were compared with patients in a control group who got standard treatments.

“None of the aggressive treatments significantly reduced the risk of heart attacks, strokes, or other cardiovascular complications,” reported the VOA.

Voice of America cited ACCORD researcher William Cushman who said, “Our composite cardiovascular outcome of dying from cardiovascular events or having a non-fatal heart attack or a non-fatal stroke, that combined outcome was not significantly reduced.”

We have reported similar finding in the past, but this research did uncover a benefit that perhaps they had not anticipated from tight blood glucose control. The VOA report stated, “One positive outcome from the ACCORD study was evidence supporting ways to improve what doctors call diabetes patients’ microvascular conditions. The disease affects small blood vessels in a way that can damage nerves, kidneys and the eyes. So, Emily Chew of the National Eye Institute noted that aggressive lowering of blood sugar or cholesterol levels helped control the progression of eye disease.”

Since one of the major long-term symptoms of diabetes is blindness and retinopathy this is actually very significant. In many cases diabetics must undergo eye surgery to save their vision as diabetes progresses. This new information suggests it is possible to either delay or perhaps even stop the advance of retinopathy and blindness in diabetics through effective blood glucose control.

As we reported earlier the VOA report confirms yet again, “In another part of the ACCORD study, patients got intensive therapy to lower their blood sugar. After three and a half years, the group getting intensive therapy was switched into the control group, to standard therapy, because they were dying at a higher rate.”

Some researchers suggest that the study should be expanded to see what results might be seen in younger patients who live with diabetes. Perhaps, it is theorized, there can be positive results from very tight control when a patient is younger. The treatment could then be altered as they age.

What most are concluding from the new information found in recent editions of The Lancet and The New England Journal of Medicine is that tight blood glucose control may be problematic for those who are known to have cardiovascular issues. The same is true for those who have diagnosed kidney disease.

As medical science continues to explore the causes and control of diabetes more becomes known about the treatment of the disease. While this information is counter to general thought it can and should result in better long-term care for diabetic patients.

As with all of life working toward a better balance of control and outcome is the best-case scenario for diabetes.

New Links Connecting Diabetes and Fast Food

Diabetes and fast food can co-exist but count your carbs & get exercise. What is true in the United States seems to be true of many other nations when it comes to diabetes. When the population as a whole gains weight the instances of diabetes increases. Research in one Asian country seems to blame western fast food for the dramatic rise in diabetes.

Garvan Institute of Medical Research

Australia’s Garvan Institute of Medical Research conducted the study in Ho Chi Minh City, Vietnam. The BBC reported that, “about 11% of men and 12% of women… had undiagnosed type 2 diabetes.” This didn’t count the 4% who had already been confirmed as having diabetes.

Professor Tuan Nguyen of the Garvan Institute told the BBC, “Dietary patterns have been changing dramatically in Vietnam in recent years, particularly in the cities as they become more Westernized.”

It seems that studies in various other Asian countries point to the potential of fast food and a change in lifestyle as the predominant reason for the spread of diabetes.

I suppose the greatest difficulty for leaders of any country is that food is the one area that can be hard to police and may be viewed as a harsh and unusual form of control. Many choose fast food for convenience while other choose it for taste. In all cases it is a sense of freedom that predicates the choice of what food is ultimately consumed.

Diabetes and Fast Food in the US

In America where the financial system is built on capitalism it can be hard to deny paying customers the food items for which they are willing to pay. If a fast food restaurant moved toward a position of only serving health food they may find that their customer base would shrink dramatically. In fact the success of U.S. fast food chains has convinced them they have a formula that works. From a business standpoint it makes sense to export the product and increase their profitability.

Most people do not want someone telling them what they can and can’t eat. Fast food restaurants certainly aren’t going to be the ones to force you to eat something you don’t want. However, they will change direction when customers demand changes.

Any changes that we are going to see in fast food restaurants will be because we, as consumers, make different choices. If restaurants discover that a healthier product will sell they will begin offering healthier foods in general. The menu of virtually every restaurant is consumer driven.

Restaurant owners want to be successful in business so they will be responsive to consumer demand.

To put this in perspective you need to know that as a diabetic or pre-diabetic the changes you need to make will be changes you personally make. Fast food restaurants will not change their menu simply because you have dietary restrictions. You will be responsible for your own diet and lifestyle.

At some point one has to think that when/if diabetes becomes an epidemic it will become the best interest of the fast food restaurants to alter their menu because at that point it is conceivable those with diabetes will sadly become a group large enough to tip the balance in favor of healthy foods and adjusted portion sizes.

However, instead of waiting for this scenario to happen you can take control of your health and begin making personal changes today – on your own. This self-disciplined approach frees you from having to wait until a universal change takes place in what truly would be a worse case scenario.

Pay for Performance: Medicare Hurting Diabetics

The idea of paying for high performing health care providers seems like a good idea, but new laws spelled out in the Health Care overhaul could mean that some diabetics on Medicare could find even limited services cut.

The idea of paying for high performing health care providers seems like a good idea, but new laws spelled out in the Health Care overhaul could mean that some diabetics on Medicare could find even limited services cut.

According to a press release in ScienceDaily.com, “The planned nationwide implementation of institutional bonuses mandated under federal health care reform threatens to … [cause] hospitals in less-advantaged regions to lose funds to health care facilities in more affluent areas of the country, according to a study published in the academic journal PLoS Medicine.”

Researchers from New York University, Cornell University, and Harvard University say, “Pay-for-performance assumes that providers have adequate economic and human resources to perform, or improve their performance, within a short time frame. Yet the prevailing distribution of resources in the U.S. health care system makes it difficult for some providers to operate effectively as it is. Payment based on performance may worsen inequalities, as hospitals in under-resourced areas lose funds to their better-off counterparts, with the government acting as a sort of ‘reverse Robin Hood.’ ”

In essence what this policy does is potentially penalize rural health care centers because they don’t have the staff or patient volume to fairly compete with larger medical centers. When they can’t match performance the already struggling rural counterpart is penalized as extra Medicare funds are shifted to the high performance medical centers. The end result would appear to be a lack of quality care for rural residents – unless they are willing to travel to larger clinics in more urban areas. Often this is inconvenient and impractical.

The ScienceDaily.com release explains more about how the new system would work, “Offering bonuses to doctors when they reach pre-determined targets, such as for the regularity of blood sugar checks for patients with diabetes, is a practice that has been adopted widely over the past decade by countries with rapidly aging populations and rising health costs, among them the UK, Australia and Taiwan. Pay-for-performance has also been used in the United States, albeit in a piecemeal fashion. Now, however, the U.S. is poised to evaluate hospitals in Medicare’s “Value Based Purchasing” (VBP) program, and, based on results, to reward those that improve, and reduce reimbursements for those that fail to show progress toward performance targets. The first wave of nationwide evaluation under this federally mandated effort, slated to begin in 2012, will focus on hospital performance on process-of-care measures for common conditions such as heart attack and pneumonia. Later, VBP will likely be extended to other metrics such as risk-adjusted patient death rates.”

This report does point out that there is a window of opportunity “to modify and improve upon the current version” of the new mandate before implementation in 2012. The study concludes, “”Holding providers accountable is not an unreasonable approach to quality improvement, but it must be done in a way that attends to the profound inequalities in local circumstances that shape life in the twenty-first century.”

Critics indicate that this plan could lead to health care rationing while others suggest the language should be addressed and will likely be changed. Those who view this as detrimental to Medicare patients in rural or under-served areas find the prospect less than ideal for patients who have come to rely on local care in familiar surroundings.

Health care remains a critical topic to all Americans, but the notion of decreased services for under-performing medical centers could potentially create significant gaps in care for Medicare patients struggling with diabetes.

Health Committee Overview

Recently the U.S. Government Subcommittee on Health convened to discuss the overall progress on diabetes in the United States.

Recently the U.S. Government Subcommittee on Health convened to discuss the overall progress on diabetes in the United States. What follows are highlights from that subcommittee meeting.

Ann Albright, PhD, RD
Director, Division of Diabetes Translation

“Several research studies… have demonstrated that a structured lifestyle program, which results in a modest weight loss of 5 to 7 percent while encouraging a healthy diet and increasing physical activity, can reduce risk for type 2 diabetes by 58 percent in those at high risk for diabetes or who have pre-diabetes. Based on the findings of the Diabetes Prevention Program clinical trial and subsequent NIH-supported studies that have translated these research findings into real world settings, CDC and our partners are implementing the National Diabetes Prevention Program. This program focuses on delivering the proven intervention in-group settings for a cost of about $250 to $300 per person per year. The National Diabetes Prevention Program takes a four-pronged approach: training the workforce, a recognition program for quality assurance, funding sites to deliver the intervention, and health marketing to increase the program’s utilization.”

Judith E. Fradkin, M.D.
Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

“One approach to combat the diabetes epidemic in the U.S. is to prevent the disease. The Diabetes Prevention Program (DPP) clinical trial showed that people with pre-diabetes-defined as having blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes–can dramatically reduce their risk of developing type 2 diabetes through lifestyle changes that achieve modest weight loss or through treatment with the drug metformin, although the metformin intervention was much less effective than the lifestyle intervention. The interventions worked in all ethnic and racial groups studied, in both men and women, and in women with a history of gestational diabetes. Research now shows that, after a 10-year period of following DPP participants, the interventions result in long-term benefits: people still had a lower risk of developing type 2 diabetes and those who made lifestyle changes also had reduced cardiovascular risk despite taking fewer drugs to control their heart disease risk factors?”

Robert A. Goldstein, M.D. PH.D.
Senior Vice President, Scientific Affairs for the Juvenile Diabetes Research Foundation International

Promising research include(s):

  • Vaccine to Prevent Type 1 Diabetes Onset: Research toward the development of a vaccine to reverse the immune attack that causes diabetes holds great promise for type 1 diabetes patients. NIH- and JDRF-funded researchers have successfully cured and prevented type 1 diabetes in mice using a vaccine made of nanoparticles thousands of times smaller than the size of a cell, coated with proteins involved in immune cell communication. Thanks to NIH funds from the Special Diabetes Program, researchers have shown that these particles are safe for use in humans.

“The NIH, JDRF and privately-funded researchers are also working on promising vaccine therapies to preserve beta cell function in people newly diagnosed with type 1 diabetes.”

If you read articles on this site you know there are plenty of promising research statistics along with new discoveries that are providing hope and answers to diabetics. This subcommittee hearing was designed to bring top minds together to point out new avenues in which diabetic research can go and applaud those things that have been successful in facilitating change in the way we deal with the disease.

There will always be something to work on, but as demonstrated above there are also hurdles that have already been crossed.

Secret Link